Novel Drug Benefits Bone and Cartilage in Knee Osteoarthritis

An investigational selective cathepsin K inhibitor called MIV-711 failed to decrease knee osteoarthritis pain but attenuated bone area progression and reduced cartilage volume loss, a multicenter European trial reported in the Annals of Internal Medicine.
Source: JAMA - Category: General Medicine Source Type: research